Actionnariat et activité des initiés pour Relmada Therapeutics, Inc. (RLMD): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.22 |
| Capitalisation | $443M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-10 | Shenouda Maged | P-Purchase | 79,800 | $339K |
| 2026-09-09 | Shenouda Maged | P-Purchase | 120,200 | $505K |
| 2026-09-10 | TRAVERSA SERGIO | P-Purchase | 100,000 | $410K |
| 2026-09-09 | TRAVERSA SERGIO | P-Purchase | 100,000 | $418K |
| 2025-12-15 | TRAVERSA SERGIO | P-Purchase | 27,500 | $113K |
| 2025-12-12 | TRAVERSA SERGIO | A-Award | 1,198,000 | $4.9M |
| 2025-12-12 | Shenouda Maged | A-Award | 828,000 | $3.4M |
| 2025-12-15 | Shenouda Maged | P-Purchase | 11,665 | $48K |
| 2025-12-12 | Ence Chuck | A-Award | 828,000 | $3.4M |
| 2025-12-12 | Fedeli Fabiana | A-Award | 164,000 | $666K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.7M | $2.2M | $9.2M | $36.3M | $2.5M | $44.4M | $5.4M | $4.1M | $3.9M | $3.5M |
| Placements à Court Terme | 0 | 0 | 0 | $80.2M | $114.6M | $167.5M | $142.9M | $92.2M | $41.1M | $89.5M |
| Créances | $291916 | $72103 | $247082 | $73091 | $79457 | $86377 | $512432 | 0 | 0 | 0 |
| Stocks | $472500 | $426900 | $459000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $2.5M | $2.7M | $10.0M | $116.9M | $118.1M | $223.3M | $152.9M | $97.5M | $45.8M | $94.0M |
| Immobilisations Corporelles | $2315 | $12080 | $7210 | $5010 | $1258 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $2.8M | $3.0M | $10.2M | $117.1M | $118.2M | $223.3M | $152.9M | $97.6M | $45.8M | $94.0M |
| Dettes Fournisseurs | $529558 | $765439 | $924359 | $522663 | $8.3M | $11.2M | $5.3M | $3.5M | $4.1M | $1.6M |
| Dette à Court Terme | $276670 | $285170 | $364204 | $110247 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.4M | $5.9M | $2.6M | $1.5M | $12.6M | $15.1M | $12.5M | $12.2M | $10.3M | $6.4M |
| Dette à Long Terme | 0 | $2.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.4M | $8.6M | $2.6M | $1.5M | $12.6M | $15.1M | $12.5M | $12.2M | $10.3M | $7.5M |
| Réserves | -$85.4M | -$94.3M | -$111.7M | -$119.9M | -$179.3M | -$305.1M | -$462.1M | -$560.9M | -$640.9M | -$698.3M |
| Capitaux Propres | $1.5M | -$5.5M | $7.6M | $115.7M | $105.6M | $208.3M | $140.4M | $85.4M | $35.5M | $86.5M |
| Dette Totale | $276670 | $2.9M | $364204 | $110247 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dette Nette | -$1.4M | $702684 | -$8.9M | -$116.3M | -$117.1M | -$211.9M | -$148.3M | -$96.3M | -$44.9M | -$93.0M |
| Fonds de Roulement | $1.1M | -$3.2M | $7.4M | $115.5M | $105.5M | $208.2M | $140.4M | $85.3M | $35.5M | $87.6M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 29.52 |
Rentabilité
| Rentabilité des capitaux propres | -47.52% |
| Rentabilité du capital investi | -30.78% |
| Rentabilité des actifs | -28.27% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACET · ACRV · CBUS · FBIO · IMUX · LITS · PMVP
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de RLMD: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions